Huifeng Niu

Huifeng Niu is a seasoned professional in the field of translational medicine, currently serving as the Vice President and Global Head of Translational Medicine at Hansoh Bio since September 2021. Prior experience includes roles at Takeda Pharmaceuticals from 2012, where Niu progressed from Associate Director to Director of Translational Medicine, and a significant tenure at Roche from 2001 to 2012, where Niu held various leadership positions including Senior Research Leader. Educational qualifications include a Doctor of Philosophy (Ph.D.) in Pharmacology and Molecular Biology from The Chicago Medical School, a Master's degree in Biochemistry from the Institute of Microbiology at the Chinese Academy of Sciences, and a Bachelor's degree in Microbiology from Nankai University, alongside postdoctoral training in cancer genetics and signaling pathways in lymphomas at Columbia University Vagelos College of Physicians and Surgeons.